dactinomycin has been researched along with tamoxifen aziridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agresti, M; Fine, RL; Roberts, S; Safa, AR | 1 |
BorrĂ¡s, M; el Khissiin, AH; Gol-Winkler, R; Hardy, L; Leclercq, G; Legros, N; Lempereur, F | 1 |
2 other study(ies) available for dactinomycin and tamoxifen aziridine
Article | Year |
---|---|
Tamoxifen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells.
Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Line; Colchicine; Cricetinae; Cricetulus; Dactinomycin; Doxorubicin; Drug Resistance; Kinetics; Lung; Membrane Glycoproteins; Tamoxifen; Tritium; Vinblastine; Vincristine | 1994 |
Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression.
Topics: Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Estrone; Half-Life; Humans; Intercalating Agents; Kinetics; Molecular Weight; Phosphoric Monoester Hydrolases; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Tritium; Tumor Cells, Cultured | 1994 |